United Therapeutics (UTHR) Net Margin (2009 - 2026)
United Therapeutics (UTHR) reported Net Margin of 35.18% for Q1 2026, down 538.0% on a YoY basis from 8.03% in Q1 2025, and down 23.7% sequentially from 46.1% in Q4 2025.
United Therapeutics (UTHR) Net Margin (2009 - 2026) Analysis & Trends
United Therapeutics (UTHR) has 18 years of Net Margin data on file, last reported at 35.18% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin fell 538.0% year-over-year to 35.18%; the trailing twelve-month figure through Mar 2026 stood at 40.61% (up 18.0% YoY), and the FY2025 full-year result was 41.94%, up 40.0% from the prior year.
- Net Margin retreated to 35.18% in Q1 2026, from 46.1% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 51.94% in Q1 2022 to a low of 24.84% in Q2 2022.
- A 5-year average of 40.56% and a median of 41.27% in 2024 frame the typical range for Net Margin.
- Peak annual rise in Net Margin reached 4447 bps in 2022, while the deepest fall reached 1381 bps in 2022.
- Tracing UTHR's Net Margin over 5 years: stood at 26.88% in 2022, then jumped by 31 bps to 35.32% in 2023, then gained by 16 bps to 40.94% in 2024, then rose by 13 bps to 46.1% in 2025, then decreased by 24 bps to 35.18% in 2026.
- Business Quant data shows UTHR's Net Margin at 35.18% in Q1 2026, 46.1% in Q4 2025, and 42.36% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 9.29% |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 26.57% |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -33.66% |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 35.18% |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 5.03% |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 24.30% |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 4.16% |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | -21.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.18% |
| Dec 31, 2025 | 46.10% |
| Sep 30, 2025 | 42.36% |
| Jun 30, 2025 | 38.76% |
| Mar 31, 2025 | 40.56% |
| Dec 31, 2024 | 40.94% |
| Sep 30, 2024 | 41.27% |
| Jun 30, 2024 | 38.90% |
| Mar 31, 2024 | 45.24% |
| Dec 31, 2023 | 35.32% |
| Sep 30, 2023 | 43.91% |
| Jun 30, 2023 | 43.45% |
| Mar 31, 2023 | 47.52% |
| Dec 31, 2022 | 26.88% |
| Sep 30, 2022 | 46.38% |
| Jun 30, 2022 | 24.84% |
| Mar 31, 2022 | 51.94% |
| Dec 31, 2021 | 27.02% |
| Sep 30, 2021 | 36.59% |
| Jun 30, 2021 | 38.66% |